The high consistency of calculated lg10(fold change) values of both differential gene expression analysis and the robust expression level in cell lines suggest linear TRAM1 RNA species as potential candidates for tumor markers with reduced expression in higher cancer stages. This evidence concerns the gene TRAM1 and cancer.